Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of 1.2 billion to 1.4 billion yuan in 2025, representing a year-on-year growth of 16.27% to 35.64% [1] Company Performance - The increase in performance is primarily driven by simultaneous growth in sales price and sales volume [1] - The edible mushroom industry is stabilizing and recovering after a long adjustment period, leading to improved market conditions that push the prices of the company's main products into an upward trend [1] - The expansion of production capacity has contributed to an increase in sales volume, which, along with the aforementioned factors, has led to an improvement in gross profit margin and a significant increase in net profit compared to the previous year, resulting in a turnaround from losses to profits [1]
华绿生物：预计2025年归母净利润为12亿元至14亿元